Altimmune (ALT) had the highest return in 2017 by a US stock with a market cap of $100M+, returning 29,849,900%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Altimmune (ALT) | 2017 | 29,849,900% |
HIVE Digital Technologies (HIVE) | 2017 | 3,814.29% |
TSS, Inc Common Stock (TSSI) | 2017 | 1,200% |
Lexinfintech (LX) | 2017 | 1,077.89% |
Gravity (GRVY) | 2017 | 801.73% |
Riot Platforms (RIOT) | 2017 | 782.18% |
Cronos (CRON) | 2017 | 592.83% |
AnaptysBio (ANAB) | 2017 | 529.5% |
Madrigal Pharmaceuticals (MDGL) | 2017 | 513.98% |
Village Farms International (VFF) | 2017 | 474.78% |
Palvella Therapeutics (PVLA) | 2017 | 447.1% |
Fennec Pharmaceuticals (FENC) | 2017 | 402% |
Nektar Therapeutics (NKTR) | 2017 | 378.53% |
Aurora Cannabis (ACB) | 2017 | 343.62% |
Talos Energy (TALO) | 2017 | 322.29% |
Quantum Computing (QUBT) | 2017 | 300% |
Xunlei Ltd Adr (XNET) | 2017 | 298.7% |
Global Industrial (GIC) | 2017 | 281.26% |
Assembly Biosciences (ASMB) | 2017 | 276.93% |
BioLife Solutions (BLFS) | 2017 | 270.37% |
Neighborhood Intelligence, Inc Common Stock (NXH) | 2017 | 269.37% |
Pulse Biosciences (PLSE) | 2017 | 263.08% |
Avalo Therapeutics (AVTX) | 2017 | 259.55% |
argenx NV ADR (ARGX) | 2017 | 252.74% |
DeFi Technologies (DEFT) | 2017 | 252.37% |